首页 | 本学科首页   官方微博 | 高级检索  
检索        

非黏附骨髓源干细胞治疗急性放射损伤
作者姓名:王盼君  傅晋翔  孙 谕  冯一中  张 宏  张学光
作者单位:苏州大学附属第二医院,1血液科,2病理科,3检验科,江苏省苏州市 215004;4苏州大学生命科学学院生物技术研究所,江苏省苏州市 215004
摘    要:背景:目前对于辐射剂量超过8 Gy的急性放射病尚缺乏有效的治疗方案,间充质干细胞可以分泌多种造血因子、重建造血,在放射损伤救治中具有重要意义。 目的:探讨非黏附骨髓源干细胞在8.5 Gy X射线照射所致急性骨髓型放射损伤救治中的作用及作用机制。 方法:取胎儿四肢长骨的非黏附骨髓源干细胞,分析其麦面抗原,细胞周期,成骨和成脂分化潜能,以及血管内皮生长因子及Annexin A2表达。BALB/C小鼠受8.5 Gy一次性全身均匀X射线照射后随机分成骨髓源干细胞组和对照组,骨髓源干细胞组小鼠在X射线照射2 h内经尾静脉输注含3×106 CFDA-SE标记的人非黏附骨髓源干细胞的细胞悬液0.3 mL,对照组小鼠在X射线照射2 h内输注0.3 mL生理盐水。观察骨髓源干细胞的分布情况、小鼠的存活率、白细胞变化、骨髓病理变化及骨髓中新生血管形成情况。 结果与结论:X射线照射后移植的非黏附间充质干细胞可以向损伤部位归巢;骨髓源干细胞组小鼠存活率明显高于对照组;与对照组相比,骨髓源干细胞组小鼠外周血白细胞计数下降慢且恢复迅速,X射线照射后14 d左右达最低,30 d基本恢复至正常水平。X射线照射后21 d,骨髓源干细胞组骨髓增生活跃,骨髓腔内新生造血灶显著多于对照,血管密度亦显著高于对照组。说明人胎儿非黏附骨髓源干细胞促进急性放射损伤小鼠骨髓内新生血管形成,改善并加快受损小鼠造血功能的恢复。

关 键 词:干细胞  骨髓干细胞  非黏附骨髓源干细胞  间充质干细胞  急性放射损伤  血管新生  微血管密度  血管内皮生长因子  归巢  干细胞图片文章  
收稿时间:2013-03-25

Therapeutic potential of non-adherent bone marrow-derived stem cells for acute radiation injury
Authors:Wang Pan-jun  Fu Jin-xiang  Sun Yu  Feng Yi-zhong  Zhang Hong  Zhang Xue-guang
Institution:1Department of Hematology, Second Affiliated Hospital of Soochow University, Suzhou  215004, Jiangsu Province, China; 2Department of Pathology, Second Affiliated Hospital of Soochow University, Suzhou  215004, Jiangsu Province, China; 3Clinical Laboratory, Second Affiliated Hospital of Soochow University, Suzhou  215004, Jiangsu Province, China; 4Institute of Biotechnology, College of Life Sciences, Suzhou University, Suzhou  215004, Jiangsu Province, China
Abstract:BACKGROUND: Effective treatment for severed acute radiation sickness (over 8 Gy) has not been obtained at present. Mesenchymal stem cells, which are shown to secrete hematopoietic cytokines and support hematopoietic progenitors, play an important role in cute radiation sickness. OBJECTIVE: To investigate the therapeutic potential of non-adherent bone marrow-derived stem cells in the treatment of acute radiation injury induced by 8.5 Gy X-ray irradiation, as well as the mechanisms involved.  METHODS: Non-adherent marrow-derived stem cells from the long bone of fetal limbs were collected for analyzing surface antigens, cell cycle, osteogenic and adipogenic differentiation potential, and expressions of vascular endothelial growth factors and Annexin A2. After being exposed to 8.5 Gy total body irradiation, BALB/C mice were randomly assigned into transplantation group and control group. Mice in the transplantation group were given 3×106 CFDA-SE labeled human non-adherent bone marrow-derived stem cells, and those in the control group were given 0.3 mL normal saline. Then, the survival rate, peripheral white blood cells at different time, pathologic change and angiogenesis of the bone marrow were observed. RESULTS AND CONCLUSION: After X-ray irradiation, transplanted non-adherent mesenchymal stem cells appeared to have a homing to the site of injury. The survival rate of mice in the transplantation group was much higher than that in the control group. Compared with the control group, the white blood cells in the transplantation group decreased more slowly while recovered more rapid: the nadir appeared at day 14 after transplantation while it recovered within 30 days. The bone marrow of mice in the transplantation group regenerated more actively and had more hematopoietic islands than those in the control group on day 21. In addition, bone marrow angiogenesis of the transplantation group was more obvious than that of the control group. In conclusion, human fetal non-adherent bone marrow-derived stem cells could promote bone marrow angiogenesis in a mouse model of acute radiation injury, through which they could play an important role in tissue regeneration of acute radiation injury.
Keywords:stem cells  bone marrow-derived stem cells  non-adherent bone marrow-derived stem cells  mesenchymal stem cells  acute radiation injury  angiogenesis  microvessel density  vascular endothelial growth factor  homing  stem cell photographs-containing paper  
点击此处可从《》浏览原始摘要信息
点击此处可从《》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号